Company: CXDO
Filing Date: 2025-03-04
Form Type: 10-K
Source: 0001654954-25-002287
Chunk: 294

Company: Crexendo, Inc.
Filing Date: 2025-03-04
Form: 10-K
Item: Item 1A
Chunk 294
---
 compensation is a component of operating expense, the impact on our financial statements compared to other companies can vary significantly due to such factors as the assumed life of the options and the assumed volatility of our common stock; and ·other companies may calculate EBITDA and Adjusted EBITDA differently than we do, limiting their usefulness as comparative measures.

We compensate for these limitations by relying primarily on our U.S. GAAP results and using Non-GAAP net income, EBITDA, and Adjusted EBITDA only as supplemental support for management’s analysis of business performance. Non-GAAP net income, EBITDA and Adjusted EBITDA are calculated as follows for the periods presented.

Reconciliation of Non-GAAP Financial Measures

In accordance with the requirements of Regulation G issued by the SEC, we are presenting the most directly comparable U.S. GAAP financial measures and reconciling the unaudited Non-GAAP financial metrics to the comparable U.S. GAAP measures.

Reconciliation of U.S. GAAP Net Income to Non-GAAP Net Income

(Unaudited, in thousands, except per share and share data)

  Three Months Ended December 31,  Year Ended December 31,   2024  2023  2024  2023   (In thousands)  (In thousands) U.S. GAAP net income/(loss) $507  $61  $1,677  $(362)Share-based compensation  709   737   3,002   3,849 Acquisition related expenses  -   -   -   1 Amortization of intangible assets  755   792   3,028   3,169 Non-GAAP net income $1,971  $1,590  $7,707  $6,657                  Non-GAAP earnings per common share:                Basic $0.07  $0.06  $0.29  $0.26 Diluted $0.06  $0.06  $0.26  $0.24                  Weighted-average common shares outstanding:                Basic  27,195,382   26,072,529   26,757,242   25,944,748 Diluted  30,547,245   28